Designer T cells fight viruses after transplants

June 25, 2014 by Lauran Neergaard
This handout photo provided by Baylor College of Medicine, taken June 20, 2014, shows Dr. Ann Leen in the Center for Cell and Gene Therapy storing frozen samples of T cells designed to fight multiple viruses, at the Baylor College of Medicine in Houston. Scientists are developing a way to protect recipients of bone marrow transplants from serious viral infections in the months before their new immune system kicks in. (AP Photo/Agapito Sanchez, Baylor College of Medicine)

Bone marrow transplants save thousands of lives but patients are vulnerable to severe viral infections in the months afterward, until their new immune system kicks in. Now scientists are developing protection for that risky period—injections of cells specially designed to fend off up to five different viruses at once.

"These are a huge problem, and there's a huge need for these products," said Dr. Ann Leen, who leads a team at Baylor College of Medicine and Texas Children's Hospital that found an easier way to produce these long-desired designer T .

Healthy people have an army of T cells that roams the body, primed to recognize and fight viruses. People with suppressed immune systems—such as those undergoing a transplant to treat leukemia or other diseases—lack that protection. It can take anywhere from four months to more than a year for marrow from a healthy donor to take root and start producing new immune cells for the recipient. When patients get sick before then, today's antiviral medications don't always work and cause lots of side effects.

The proposed solution: Take certain virus-fighting T cells from that same , and freeze them to use if the recipient gets sick. Years of experiments show it can work. But turning the idea into an easy-to-use treatment has been difficult. A dose had to be customized to each donor-recipient pair and protected against only one or two viruses. And it took as long as three months to make.

Wednesday, Leen reported a novel technique to rapidly manufacture so-called virus-specific T cells that can target up to five of the viruses that cause the most trouble for : Epstein-Barr virus, adenovirus, cytomegalovirus, BK virus, and human herpesvirus 6.

This handout photo provided by Baylor College of Medicine, taken June 20, 2014, shows Dr. Ann Leen in the Center for Cell and Gene Therapy holding a vial containing T cells designed to fight multiple viruses, at the Baylor College of Medicine in Houston. Scientists are developing a way to protect recipients of bone marrow transplants from serious viral infections in the months before their new immune system kicks in. (AP Photo/Agapito Sanchez, Baylor College of Medicine)

Essentially, Leen came up with a recipe to stimulate donated T cells in the laboratory so that they better recognize those particular viruses, and then grow large quantities of the cells. It took just 10 days to create and freeze the designer T cells.

To see if they worked, Leen's team treated 11 transplant recipients. Eight had active infections, most with multiple viruses. The cell therapy proved more than 90 percent effective, nearly eliminating all the viruses from the blood of all the patients, Leen reported in the journal Science Translational Medicine.

The other three patients weren't sick but were deemed at high risk. They were given early doses of the T cells protectively and remained infection-free, Leen said.

Next, her team is beginning a bigger step—to try creating a bank of those cells from a variety of healthy donors that any patient could use, without having to custom-brew each dose.

It would take large studies to prove such a system really works.

But Leen's technique makes production of these T cells practical instead of laborious, said Dr. John Barrett of the National Institutes Health, who wasn't involved with the new research.

"It's a step further to making this something that could be done not just in ivory towers," but one day by a drug company, said Barrett, a specialist at NIH's National Heart, Lung and Blood Institute.

Different varieties of custom-made T cells have proved effective in a series of small studies, added Dr. Richard O'Reilly, pediatrics chief at Memorial Sloan Kettering Cancer Center and another pioneer of the approach.

"It's just very, very hard and very expensive to generate cells from each transplant donor against each virus," he said. "What this is showing is that you can make T cells against a series—and these are the most important viruses that we deal with—and you can make enough of these T cells to make a difference."

Explore further: Transfer of a few immune cells can protect immunodeficient patients

More information: "Activity of Broad-Spectrum T Cells as Treatment For AdV, EBV, CMV, BKV, and HHV6 Infections After HSCT," by A. Papadopoulou et al. stm.sciencemag.org/lookup/doi/ … scitranslmed.3008825

Related Stories

Transfer of a few immune cells can protect immunodeficient patients

June 17, 2014
When patients have to undergo a bone marrow transplant, the procedure weakens their immune system. Viruses that are usually kept in check in a healthy immune system may then cause potentially fatal infections. Scientists ...

Scientists use stem cells to create HIV resistance

June 10, 2014
(Medical Xpress)—Yuet Wai Kan of the University of California, San Francisco and colleagues have created HIV-resistant white blood cells by editing the genomes of induced pluripotent stem cells. The researchers inserted ...

Novel drug prevents common viral disease in stem-cell transplant patients, study finds

September 25, 2013
A new drug can often prevent a common, sometimes severe viral disease in patients receiving a transplant of donated blood-making stem cells, a clinical trial led by researchers at Dana-Farber Cancer Institute and Brigham ...

Immune cells regulate blood stem cells

February 21, 2014
Researchers in Bern, Germany, have discovered that, during a viral infection, immune cells control the blood stem cells in the bone marrow and therefore also the body's own defences. The findings could allow for new forms ...

Finding hiding place of virus could lead to new treatments

March 11, 2014
Discovering where a common virus hides in the body has been a long-term quest for scientists. Up to 80 percent of adults harbor the human cytomegalovirus (HCMV), which can cause severe illness and death in people with weakened ...

New possibilities for leukemia therapy with a novel mode of leukemia cell recognition

June 24, 2014
Scientists at A*STAR's Singapore Immunology Network (SIgN) have discovered a new class of lipids in the leukaemia cells that are detected by a unique group of immune cells. By recognising the lipids, the immune cells stimulate ...

Recommended for you

A sodium surprise: Engineers find unexpected result during cardiac research

July 20, 2017
Irregular heartbeat—or arrhythmia—can have sudden and often fatal consequences. A biomedical engineering team at Washington University in St. Louis examining molecular behavior in cardiac tissue recently made a surprising ...

Want to win at sports? Take a cue from these mighty mice

July 20, 2017
As student athletes hit training fields this summer to gain the competitive edge, a new study shows how the experiences of a tiny mouse can put them on the path to winning.

Engineered liver tissue expands after transplant

July 19, 2017
Many diseases, including cirrhosis and hepatitis, can lead to liver failure. More than 17,000 Americans suffering from these diseases are now waiting for liver transplants, but significantly fewer livers are available.

Lunatic Fringe gene plays key role in the renewable brain

July 19, 2017
The discovery that the brain can generate new cells - about 700 new neurons each day - has triggered investigations to uncover how this process is regulated. Researchers at Baylor College of Medicine and Jan and Dan Duncan ...

'Smart' robot technology could give stroke rehab a boost

July 19, 2017
Scientists say they have developed a "smart" robotic harness that might make it easier for people to learn to walk again after a stroke or spinal cord injury.

New animal models for hepatitis C could pave the way for a vaccine

July 19, 2017
They say that an ounce of prevention is worth a pound of cure. In the case of hepatitis C—a disease that affects nearly 71 million people worldwide, causing cirrhosis and liver cancer if left untreated—it might be worth ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.